AI Verdict
JSPRW has stronger fundamentals based on our AI analysis.
JSPRW vs JSM Fundamental Comparison
| Metric | JSPRW | JSM |
|---|---|---|
| Revenue | $-246,000.0 | $3.1B |
| Net Income | $-75.8M | $-80.0M |
| Net Margin | 30,813.4% | -2.6% |
| ROE | -1,826.1% | -3.3% |
| ROA | -211.9% | -0.2% |
| Current Ratio | 2.62x | N/A |
| Debt/Equity | 0.00x | 16.94x |
| EPS | $-3.95 | $-0.81 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
JSPRW vs JSM: Frequently Asked Questions
Is JSPRW or JSM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JSPRW has stronger fundamentals. JSPRW is rated STRONG SELL (85% confidence) while JSM is rated STRONG SELL (72% confidence). This is not investment advice.
How does JSPRW compare to JSM fundamentally?
Jasper Therapeutics, Inc. has ROE of -1,826.1% vs NAVIENT CORP's -3.3%. Net margins are 30,813.4% vs -2.6% respectively.
Which stock pays higher dividends, JSPRW or JSM?
JSPRW has a dividend yield of N/A or no dividend while JSM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in JSPRW or JSM for long term?
For long-term investing, consider that JSPRW has STRONG SELL rating with 85% confidence, while JSM has STRONG SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about JSPRW vs JSM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For JSPRW vs JSM, the AI consensus favors JSPRW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.